← Back to Search

Cannabis Awareness and Prevention Toolkit for Reducing Youth Cannabis Use

N/A
Waitlist Available
Led By Bonnie Halpern-Felsher, Ph.D.
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to follow-up at approximately 156 weeks
Awards & highlights

Study Summary

This trial will test a free online toolkit to educate youth on cannabis use and help reduce use among them.

Who is the study for?
This trial is for middle school and high school students who are currently receiving health education at schools that have chosen to participate in the study. There are no specific exclusion criteria, so all students in these settings can potentially join.Check my eligibility
What is being tested?
The trial is testing the Stanford Cannabis Awareness and Prevention curriculum, which is an online resource aimed at increasing knowledge about cannabis and preventing its use among youth. The study will measure if this toolkit changes student attitudes towards using cannabis and their actual usage.See study design
What are the potential side effects?
Since this intervention involves educational material rather than a medical treatment, traditional physical side effects are not applicable. However, there may be psychological impacts from increased awareness or anxiety about cannabis use.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to follow-up at approximately 156 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to follow-up at approximately 156 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in cannabis use
Change in intention to use cannabis in the future

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Receives the Stanford Cannabis Prevention and Awareness curriculumExperimental Treatment1 Intervention
Stanford Cannabis Prevention and Awareness curriculum administered
Group II: Does not receive Stanford Cannabis Prevention and Awareness curriculumActive Control1 Intervention
Receives another curriculum or no cannabis prevention curriculum

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,387 Previous Clinical Trials
17,333,450 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,465 Previous Clinical Trials
2,618,033 Total Patients Enrolled
28 Trials studying Cannabis Use
5,557 Patients Enrolled for Cannabis Use
Bonnie Halpern-Felsher, Ph.D.Principal InvestigatorStanford University
1 Previous Clinical Trials
10,800 Total Patients Enrolled

Media Library

Stanford Cannabis Awareness and Prevention curriculum Clinical Trial Eligibility Overview. Trial Name: NCT05521321 — N/A
Cannabis Use Research Study Groups: Receives the Stanford Cannabis Prevention and Awareness curriculum, Does not receive Stanford Cannabis Prevention and Awareness curriculum
Cannabis Use Clinical Trial 2023: Stanford Cannabis Awareness and Prevention curriculum Highlights & Side Effects. Trial Name: NCT05521321 — N/A
Stanford Cannabis Awareness and Prevention curriculum 2023 Treatment Timeline for Medical Study. Trial Name: NCT05521321 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who has the eligibility to participate in this research endeavor?

"In order to partake in this research, participants must have a history of cannabis use and be between the ages 10 and 20. Approximately 600 individuals are being accepted into the study."

Answered by AI

Does this experimental research accept senior citizens as participants?

"For this study, the inclusion criteria demands that participants be 10 to 20 years old. Separately 18 trials are enrolling patients younger than ten and 42 for those over 65."

Answered by AI

Are there any remaining openings for this medical trial?

"As per the clinicaltrials.gov records, this medical trial is not presently accepting participants; however it was initially posted on October 1st 2022 and most recently edited 11th April 2023. Despite that, 117 other trials are currently in need of enrolment."

Answered by AI

Who else is applying?

What state do they live in?
Oklahoma
What site did they apply to?
Stanford University
What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
clinicaltrials.govStudy
Feasibility and Acceptability of the Cannabis Awareness and Prevention Toolkit
Bonnie Halpern-Felsher 2022. "Feasibility and Acceptability of the Cannabis Awareness and Prevention Toolkit". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05521321.
All > Health > Cannabis
~57 spots leftby Jul 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top